A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

被引：0
|
作者：
Park, Byeong-Bae [1 ]
Kim, Won Seog [2 ]
Suh, Cheolwon [3 ]
Yoon, Dok Hyun [3 ]
Won, Jong-Ho [4 ]
Yang, Deok-Hwan [5 ]
Do, Young-Rok [6 ]
Lee, Won Sik [7 ]
Kim, Jeong-A [8 ]
Kim, Min Kyoung [9 ]
Jo, Jae-Cheol [10 ]
Koh, Youngil [11 ]
机构：
[1] Hanyang Univ, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[4] Soonchunhyang Univ, Coll Med, Seoul, South Korea
[5] Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea
[6] Dongsan Med Ctr, Daegu, South Korea
[7] Inje Univ, Coll Med, Busan, South Korea
[8] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea
[9] Yeungnam Univ Med Ctr, Daegu, South Korea
[10] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea
[11] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1823.1823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1823
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial
    Park, Byeong-Bae
    Kim, Won Seog
    Eom, Hyeon Seok
    Kim, Jin Seok
    Lee, Young Yiul
    Oh, Suk Joong
    Lee, Dae Ho
    Suh, Cheolwon
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (01) : 154 - 160
  • [32] Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial
    Byeong-Bae Park
    Won Seog Kim
    Hyeon Seok Eom
    Jin Seok Kim
    Young Yiul Lee
    Suk Joong Oh
    Dae Ho Lee
    Cheolwon Suh
    Investigational New Drugs, 2011, 29 : 154 - 160
  • [33] The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma
    Chihara, Dai
    Fanale, Michelle A.
    Miranda, Roberto N.
    Noorani, Mansoor
    Westin, Jason R.
    Nastoupil, Loretta J.
    Hagemeister, Fredrick B.
    Fayad, Luis E.
    Romaguera, Jorge E.
    Samaniego, Felipe
    Turturro, Francesco
    Lee, Hun J.
    Neelapu, Sattva S.
    Rodriguez, M. Alma
    Wang, Michael
    Fowler, Nathan H.
    Davis, Richard E.
    Medeiros, L. Jeffrey
    Hosing, Chitra
    Nieto, Yago L.
    Oki, Yasuhiro
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 750 - 758
  • [34] Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial
    Furtado, Michelle
    Dyer, Martin J. S.
    Johnson, Rod
    Berrow, Margie
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) : 575 - 578
  • [35] Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study
    Choi, Yoon Seok
    Shim, Joonho
    Kang, Ka-Won
    Yoon, Sang Eun
    Hong, Jun Sik
    Lim, Sung Nam
    Yhim, Ho-Young
    Kwon, Jung Hye
    Lee, Gyeong-Won
    Yang, Deok-Hwan
    Oh, Sung Yong
    Shin, Ho-Jin
    Eom, Hyeon-Seok
    Yoon, Dok Hyun
    Lee, Hong Ghi
    Jeong, Seong Hyun
    Kim, Won Seog
    Kim, Seok Jin
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 267 - 279
  • [36] Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma
    Hermine, O
    Dombret, H
    Poupon, J
    Arnulf, B
    Lefrère, F
    Rousselot, P
    Damaj, G
    Delarue, R
    Fermand, JP
    Brouet, JC
    Degos, L
    Varet, B
    de Thé, H
    Bazarbachi, A
    HEMATOLOGY JOURNAL, 2004, 5 (02) : 130 - 134
  • [37] Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
    Campbell, Peter
    Thomas, Christan M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 143 - 147
  • [38] Emerging Therapies in Relapsed and Refractory Peripheral T-Cell Lymphoma
    Bachow, Spencer H.
    O'Connor, Owen A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (12) : 837 - 846
  • [39] Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
    Rashidi, Armin
    Cashen, Amanda F.
    FUTURE ONCOLOGY, 2015, 11 (11) : 1659 - 1664
  • [40] Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
    Stuver, Robert
    Moskowitz, Alison J.
    CANCERS, 2023, 15 (03)
12345